Ravi S. Chari, SVP-Clinical Excellence at HCA Healthcare, Inc. (HCA), sold 10,568 shares at $101.50 ($1.1M) on 2018-02-01, disclosed to the SEC on 2018-02-02.
Open-market sale of $1.1M HCA by SVP-Clinical Excellence. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.50 | 10,000 | $1.0M | 94.5% |
| 2 | $103.08 | 568 | $59K | 5.5% |
| Total | $101.59 avg | 10,568 | $1.1M | 100% |
| Filing → |
| HCA | SELL | 2017-03-29 | $2.9M | — | Filing → |
| HCA | SELL | 2017-02-03 | $1.3M | — | Filing → |